Bcl-2
(Redirected from BCL2)
Bcl-2
The Bcl-2 (B-cell lymphoma 2) protein is a key regulator of apoptosis, the process of programmed cell death, which is crucial for maintaining cellular homeostasis and development. Bcl-2 is part of a larger family of proteins known as the Bcl-2 family, which includes both pro-apoptotic and anti-apoptotic members. The balance between these opposing forces determines the fate of the cell.
Structure[edit | edit source]
Bcl-2 is a membrane protein that is primarily located on the outer membrane of mitochondria, but it can also be found on the endoplasmic reticulum and nuclear envelope. The protein is characterized by the presence of Bcl-2 homology (BH) domains, which are critical for its function. These domains allow Bcl-2 to interact with other proteins in the Bcl-2 family, forming heterodimers that can either promote or inhibit apoptosis.
Function[edit | edit source]
Bcl-2 functions as an anti-apoptotic protein, meaning it prevents the initiation of apoptosis. It does so by binding to and sequestering pro-apoptotic proteins such as Bax and Bak, preventing them from permeabilizing the mitochondrial outer membrane. This action inhibits the release of cytochrome c and other pro-apoptotic factors from the mitochondria, thereby blocking the activation of the caspase cascade that leads to cell death.
Role in Cancer[edit | edit source]
The overexpression of Bcl-2 is associated with several types of cancer, including B-cell lymphoma, from which it derives its name. In cancer cells, high levels of Bcl-2 can prevent apoptosis, allowing the cells to survive longer than they should, contributing to tumor growth and resistance to chemotherapy. Targeting Bcl-2 with specific inhibitors, such as venetoclax, has become a therapeutic strategy in treating certain cancers.
Research and Therapeutic Implications[edit | edit source]
Research into Bcl-2 and its family members continues to be a significant area of interest, particularly in understanding the mechanisms of apoptosis and developing new cancer therapies. Bcl-2 inhibitors are being tested in clinical trials for their efficacy in treating various malignancies.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen, Prab R. Tumpati, MD
